Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.
about
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn.The renaissance of complement therapeutics.Expanding horizons in complement drug discovery: challenges and emerging strategies.Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.
P2860
Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Long lasting neutralization of ...... complement-mediated diseases.
@en
type
label
Long lasting neutralization of ...... complement-mediated diseases.
@en
prefLabel
Long lasting neutralization of ...... complement-mediated diseases.
@en
P2093
P2860
P50
P1433
P1476
Long lasting neutralization of ...... complement-mediated diseases.
@en
P2093
Akihisa Sakamoto
Akira Hayasaka
Atsuhiko Maeda
Futa Mimoto
Genki Nakamura
Hiroyuki Tsunoda
Hitoshi Tai
Junichi Nezu
Kiyofumi Honda
Kiyoshi Habu
P2860
P2888
P356
10.1038/S41598-017-01087-7
P407
P577
2017-04-24T00:00:00Z
P6179
1084946856